PMID: 7528546Jul 1, 1994Paper

Management of bowel obstruction in advanced cancer

Current Opinion in Oncology
Carla Ripamonti

Abstract

Bowel obstruction is a common and distressing outcome in patients with abdominal or pelvic cancer. Patients may develop bowel obstruction at any time in their clinical history, with a prevalence ranging from 5.5% to 42% in those with ovarian cancer and from 10% to 28.4% in those with colorectal cancer. The causes of the obstruction may be benign postoperative adhesions, a focal malignant or benign deposit, or relapse or diffuse carcinomatosis. The symptoms, which are almost always present, are intestinal colic, continuous abdominal pain, nausea, and vomiting. Although surgery should be the primary treatment for malignant obstruction, it is now recognized that some patients with advanced disease or in generally poor condition are unfit for surgery and require alternative management to relieve distressing symptoms. A number of treatment options are now available for the patient with advanced cancer who develops intestinal obstruction. In this review, the indications for surgery are examined, the use of nasogastric tube and percutaneous gastrostomy evaluated, and the pharmacologic approach described.

Citations

Jul 11, 2006·Wiener medizinische Wochenschrift·Kurt Alker, Franz Harnoncourt
Dec 21, 2000·Current Oncology Reports·M P Davis, C Nouneh
Jun 13, 2001·Current Pain and Headache Reports·M P Davis, C Nouneh
Jun 19, 2001·Primary Care·M E Frederich
Dec 10, 1999·Critical Reviews in Oncology/hematology·P F ConteA Gadducci
Jul 13, 2002·Journal of the American College of Surgeons·Robert S KrouseGeoffrey P Dunn
Sep 7, 2007·Journal of Palliative Medicine·Yale D PodnosLawrence D Wagman
May 21, 2011·Journal of Palliative Medicine·Kimberly Moore DalalLarissa K F Temple
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·G MangiliA Ferrari
Feb 1, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D N BryanJ S Berek
Sep 12, 2012·Annals of Surgical Oncology·Colette ShawAlda Tam
Oct 8, 1998·AJR. American Journal of Roentgenology·J M RyanP R Mueller
Jun 11, 2009·Current Oncology Reports·Eric Roeland, Charles F von Gunten
Oct 19, 2000·Cancer Investigation·N I Cherny, N Hiller
Mar 15, 2006·Gastroenterology Clinics of North America·Robert S Krouse
Jan 5, 2002·Obstetrics and Gynecology Clinics of North America·D J Hewitt
Jul 9, 2004·Surgical Oncology Clinics of North America·Robert S Krouse
Mar 30, 2002·International Journal of Palliative Nursing·B Gwilliam, C Bailey
Sep 24, 1999·British Journal of Obstetrics and Gynaecology·E TsahalinaD P Barton
Mar 26, 2019·Journal of Surgical Oncology·Robert S Krouse
Sep 9, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Takeshi AramakiMichihisa Moriguchi
Feb 18, 2011·Current Opinion in Supportive and Palliative Care·Desiree F Kolomainen, Desmond P J Barton
Jun 1, 2021·Surgical Oncology Clinics of North America·Caitlin T Yeo, Shaila J Merchant

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.